Literature DB >> 31769272

"Oncofertility" procedures in children and adolescents.

Marta Tarasiewicz1, Iwo Martynowicz1, Paweł Knapp1,2, Piotr Sieczyński1.   

Abstract

One of the most important elements associated with increase in oncological outcome in children is fertility preservation for future. It is obvious that chemo and radio therapy used in cancer treatment aim to destroy tumor cells, but they also impact healthy tissues. The nega-tive influence of these types of therapy can be observed in every patient's organ. One of the most serious complication of oncological treatment is reproductive impairment. This determinates directly mental and social state of the patient as well as quality of life after the treatment, particularly in adolescent. Commonly used methods of fertility preservation in female children are: freezing ovarian tissue or unfertilized oocytes. Among male children freezing of testicular tissue or ejaculated sperm are conducted. Described methods of fertility preservation among children and adolescents are on the experimental stage and none of them provide 100% effectiveness.

Entities:  

Keywords:  adolescent; infertility; oncology; treatment; oncofertility

Mesh:

Year:  2019        PMID: 31769272     DOI: 10.5114/pedm.2019.87710

Source DB:  PubMed          Journal:  Pediatr Endocrinol Diabetes Metab        ISSN: 2083-8441


  3 in total

1.  Oocyte Biobanks: Old Assumptions and New Challenges.

Authors:  Pamela Tozzo
Journal:  BioTech (Basel)       Date:  2021-02-18

2.  Oncofertility care in young women and the outcomes of pregnancy over the last 5 years.

Authors:  Sayuri Takahashi; Akihito Horie; Sachi Yamamura; Akeo Kawamura; Ayaka Yamaguchi; Masumi Sunada; Hirohiko Tani; Haruta Mogami; Junzo Hamanishi; Eiji Kondoh; Masaki Mandai
Journal:  Future Sci OA       Date:  2021-02-02

3.  Melatonin prevents cyclophosphamide-induced primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression.

Authors:  Juan Feng; Wen-Wen Ma; Hui-Xia Li; Xiu-Ying Pei; Shou-Long Deng; Hua Jia; Wen-Zhi Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-03       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.